JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MRLN
2801
DELISTED
Marlin Business Services Corp
MRLN
| $3.17M | ﹤0.01% |
111,836
-9,481
| -8% | -$243K |
2013 Q2
19 quarters
|
|
|
PPL
2802
PUT
PPL Corp
PPL
$24.7B
| $3.17M | ﹤0.01% |
112,000
-304,200
| -73% | -$9.06M |
2017 Q1
4 quarters
|
|
|
LTXB
2803
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $3.15M | ﹤0.01% |
73,520
-37,826
| -34% | -$1.66M |
2015 Q3
10 quarters
|
|
|
BPFH
2804
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.15M | ﹤0.01% |
209,201
-9,252
| -4% | -$140K |
2013 Q2
19 quarters
|
|
2805
iShares 0-1 Year Treasury Bond ETF
SHV
$21.4B
| $3.14M | ﹤0.01% |
28,490
+24,490
| +612% | +$2.7M |
2013 Q2
19 quarters
|
|
2806
US Foods
USFD
$21B
| $3.14M | ﹤0.01% |
95,815
-230,537
| -71% | -$7.54M |
2016 Q2
7 quarters
|
|
2807
ESCO Technologies
ESE
$7.12B
| $3.14M | ﹤0.01% |
53,605
+5,014
| +10% | +$308K |
2016 Q2
7 quarters
|
|
|
PGEM
2808
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $3.13M | ﹤0.01% |
145,085
-51,375
| -26% | -$1.05M |
2013 Q2
19 quarters
|
|
2809
Rhythm Pharmaceuticals
RYTM
$6.39B
| $3.13M | ﹤0.01% |
157,453
+39,476
| +33% | +$1.05M |
2017 Q4
1 quarter
|
|
2810
PUT
Southern Company
SO
$96.3B
| $3.12M | ﹤0.01% |
69,900
-21,500
| -24% | -$954K |
2017 Q3
2 quarters
|
|
2811
CALL
Itaú Unibanco
ITUB
$94.7B
| $3.12M | ﹤0.01% |
412,299
-210,066
| -34% | -$1.57M |
2017 Q4
1 quarter
|
|
2812
Argan
AGX
$5.39B
| $3.11M | ﹤0.01% |
72,449
+7,395
| +11% | +$311K |
2013 Q2
19 quarters
|
|
2813
iShares MSCI Mexico ETF
EWW
$1.52B
| $3.1M | ﹤0.01% |
60,183
-160,467
| -73% | -$8.24M |
2013 Q2
19 quarters
|
|
2814
Super Micro Computer
SMCI
$28.7B
| $3.1M | ﹤0.01% |
1,822,270
+653,170
| +56% | +$1.31M |
2016 Q4
5 quarters
|
|
2815
Seres Therapeutics
MCRB
$29.5M
| $3.09M | ﹤0.01% |
21,056
-5,335
| -20% | -$1.02M |
2015 Q2
11 quarters
|
|
|
CLVS
2816
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.09M | ﹤0.01% |
+58,500
| New | +$3.41M |
2018 Q1
0 quarters
|
|
2817
Abeona Therapeutics
ABEO
$288M
| $3.09M | ﹤0.01% |
8,607
-784
| -8% | -$291K |
2017 Q4
1 quarter
|
|
|
TTM.RT
2818
CALL
DELISTED
TATA MOTORS LIMITED RT PUR ADR
TTM.RT
| $3.08M | ﹤0.01% |
120,000
| – | – |
2017 Q4
1 quarter
|
|
2819
Kforce
KFRC
$947M
| $3.08M | ﹤0.01% |
113,762
+11,955
| +12% | +$321K |
2015 Q4
9 quarters
|
|
|
LPSN
2820
DELISTED
LivePerson
LPSN
| $3.08M | ﹤0.01% |
12,540
-4,746
| -27% | -$950K |
2016 Q3
6 quarters
|
|
|
ESL
2821
DELISTED
Esterline Technologies
ESL
| $3.08M | ﹤0.01% |
42,066
-93,052
| -69% | -$6.93M |
2016 Q4
5 quarters
|
|
2822
Exponent
EXPO
$3.2B
| $3.07M | ﹤0.01% |
78,194
-40,148
| -34% | -$1.52M |
2013 Q2
19 quarters
|
|
2823
Upland Software
UPLD
$11M
| $3.07M | ﹤0.01% |
10,669
+3,724
| +54% | +$918K |
2017 Q2
3 quarters
|
|
2824
Voyager Therapeutics
VYGR
$151M
| $3.07M | ﹤0.01% |
163,433
+123,105
| +305% | +$2.66M |
2017 Q3
2 quarters
|
|
2825
Dr. Reddy's Laboratories
RDY
$10.2B
| $3.07M | ﹤0.01% |
469,580
-5,000
| -1% | -$35K |
2013 Q2
19 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.